FTO has been found to promote proliferation and decrease the apoptosis of pancreatic cancer cells 72, and the aforementioned FTO inhibitors might provide new therapeutic opportunities for pancreatic cancer patients. This evidence concerns the gene FTO and pancreatic neoplasm.